• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

利什曼病的药理学

The pharmacology of leishmaniasis.

作者信息

Balaña-Fouce R, Reguera R M, Cubría J C, Ordóñez D

机构信息

Department of Physiology, Pharmacology and Toxicology (INTOXCAL), University of León, Spain.

出版信息

Gen Pharmacol. 1998 Apr;30(4):435-43. doi: 10.1016/s0306-3623(97)00268-1.

DOI:10.1016/s0306-3623(97)00268-1
PMID:9580315
Abstract

The development of new strategies on chemotherapy of parasitic protozoan diseases is one of the most exciting research fields of recent years. World Health Organization (WHO) reports have recognized that the physiology and biochemistry of protozoan parasites and the host-parasite relation are the main targets for the design of new drugs that can be used in the future against these diseases.

摘要

开发针对寄生原生动物疾病的化疗新策略是近年来最令人兴奋的研究领域之一。世界卫生组织（WHO）的报告指出，原生动物寄生虫的生理学和生物化学以及宿主与寄生虫的关系是未来可用于对抗这些疾病的新药设计的主要靶点。

相似文献

1
The pharmacology of leishmaniasis.利什曼病的药理学
Gen Pharmacol. 1998 Apr;30(4):435-43. doi: 10.1016/s0306-3623(97)00268-1.
2
Leishmaniasis: some recent developments in chemotherapy.利什曼病：化疗方面的一些最新进展
J Antimicrob Chemother. 1993 Mar;31(3):327-30. doi: 10.1093/jac/31.3.327.
3
Leishmaniasis.利什曼病
Nat Rev Microbiol. 2004 Sep;2(9):692. doi: 10.1038/nrmicro981.
4
Advancement in leishmaniasis diagnosis and therapeutics: An update.利什曼病诊断和治疗的进展：更新。
Eur J Pharmacol. 2021 Nov 5;910:174436. doi: 10.1016/j.ejphar.2021.174436. Epub 2021 Aug 21.
5
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.脂质体制剂在利什曼病药理学治疗中的应用：综述。
J Liposome Res. 2017 Sep;27(3):234-248. doi: 10.1080/08982104.2017.1376682. Epub 2017 Sep 26.
6
Rational approaches for drug designing against leishmaniasis.针对利什曼病的药物设计的合理方法。
Appl Biochem Biotechnol. 2010 Apr;160(8):2208-18. doi: 10.1007/s12010-009-8764-z. Epub 2009 Sep 8.
7
Topoisomerase 1B as a target against leishmaniasis.拓扑异构酶1B作为抗利什曼病的靶点。
Mini Rev Med Chem. 2015;15(3):203-10. doi: 10.2174/138955751503150312120912.
8
Paromomycin in the treatment of leishmaniasis.巴龙霉素治疗利什曼病
Expert Opin Investig Drugs. 2008 May;17(5):787-94. doi: 10.1517/13543784.17.5.787.
9
Clinical status of agents being developed for leishmaniasis.正在研发的用于治疗利什曼病的药物的临床状况。
Expert Opin Investig Drugs. 2005 Nov;14(11):1337-46. doi: 10.1517/13543784.14.11.1337.
10
Promising therapeutic targets for antileishmanial drugs.抗利什曼原虫药物的潜在治疗靶点。
Expert Opin Ther Targets. 2002 Aug;6(4):407-22. doi: 10.1517/14728222.6.4.407.

引用本文的文献

1
Impact of Marasmic Malnutrition on Visceral Leishmaniasis: Progression and Treatment Efficacy in a Murine Model.消瘦型营养不良对内脏利什曼病的影响：小鼠模型中的疾病进展及治疗效果
Nutrients. 2025 Feb 28;17(5):849. doi: 10.3390/nu17050849.
2
Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use.抗寄生虫病媒传播疾病药物的环境影响以及将可持续性纳入其研发与使用的必要性。
Open Res Eur. 2024 Nov 4;4:207. doi: 10.12688/openreseurope.18008.2. eCollection 2024.
3
Toward New Therapeutics for Visceral Leishmaniasis: Efficacy and Mechanism of Action of Amides Inspired by Gibbilimbol B.
迈向内脏利什曼病的新疗法：受吉比利姆醇B启发的酰胺类化合物的疗效及作用机制
ACS Omega. 2024 Oct 8;9(44):44385-44395. doi: 10.1021/acsomega.4c05510. eCollection 2024 Nov 5.
4
Novel Selective and Low-Toxic Inhibitor of CPB2.8ΔCTE (CPB) One Important Cysteine Protease for Virulence.新型 CPB2.8ΔCTE（CPB）选择性和低毒抑制剂。CPB 是一种重要的毒力相关半胱氨酸蛋白酶。
Biomolecules. 2022 Dec 19;12(12):1903. doi: 10.3390/biom12121903.
5
Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review.隐丹参酮在乳腺癌治疗中的抗癌潜力；一项叙述性综述。
Front Pharmacol. 2022 Sep 16;13:979634. doi: 10.3389/fphar.2022.979634. eCollection 2022.
6
Cytotoxicity of Amphotericin B and AmBisome: and Evaluation Employing the Chick Embryo Model.两性霉素B和安必素的细胞毒性：以及采用鸡胚模型的评估
Front Pharmacol. 2022 Jun 8;13:860598. doi: 10.3389/fphar.2022.860598. eCollection 2022.
7
Leishmaniasis: where are we and where are we heading?利什曼病：我们在哪里，我们要往哪里去？
Parasitol Res. 2021 May;120(5):1541-1554. doi: 10.1007/s00436-021-07139-2. Epub 2021 Apr 7.
8
Nanoparticles for antiparasitic drug delivery.纳米颗粒用于抗寄生虫药物递送。
Drug Deliv. 2019 Dec;26(1):1206-1221. doi: 10.1080/10717544.2019.1692968.
9
Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number.婴儿利什曼原虫对别嘌醇的耐药性与染色体和基因拷贝数变异有关，包括 S-腺苷甲硫氨酸合成酶 (METK) 基因拷贝数减少。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):403-410. doi: 10.1016/j.ijpddr.2018.08.002. Epub 2018 Aug 23.
10
Iranian Native Plants on Treatment of Cutaneous Leishmaniosis: A Narrative Review.伊朗本土植物治疗皮肤利什曼病：一项叙述性综述。
Iran J Parasitol. 2017 Jul-Sep;12(3):312-322.